|
|
Blood, 15 February 2008, Vol. 111, No. 4, pp. 2220-2229.
Prepublished online as a Blood First Edition Paper on November 26, 2007; DOI 10.1182/blood-2007-07-102632.
Previous Article | Next Article 
Submitted July 23, 2007
Accepted November 11, 2007
Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy
Yulia Nefedova*, Daniel M Sullivan, Sophie C Bolick, William S Dalton, and Dmitry I. Gabrilovich
H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, United States
* Corresponding author; email: julia.nefedova{at}moffitt.org.
Drug resistance remains a critical problem in the treatment of multiple myeloma patients. Recent studies have determined that Notch signaling plays a major role in bone marrow (BM) stroma mediated protection of myeloma cells from de novo drug-induced apoptosis. Here, we investigated whether pharmacological inhibition of Notch signaling could affect the viability of myeloma cells and their sensitivity to chemotherapy. Treatment with a -secretase inhibitor (GSI) alone induced apoptosis of myeloma cells via specific inhibition of Notch signaling. At concentrations toxic for myeloma cell lines and primary myeloma cells, GSI did not affect normal BM or peripheral blood mononuclear cells. Treatment with GSI prevented BM stroma mediated protection of myeloma cells from drug-induced apoptosis. The cytotoxic effect of GSI was mediated via Hes-1 and up-regulation of the pro-apoptotic protein Noxa. In vivo experiments using xenograft and SCID-hu models of multiple myeloma demonstrated substantial antitumor effect of GSI. In addition, GSI significantly improved the cytotoxicity of the chemotherapeutic drugs doxorubicin and melphalan. Thus, this study demonstrates that inhibition of Notch signaling prevents BM mediated drug resistance and sensitizes myeloma cells to chemotherapy. This may represent a promising approach for therapeutic intervention in multiple myeloma.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Monticone, E. Biollo, A. Fabiano, M. Fabbi, A. Daga, F. Romeo, M. Maffei, A. Melotti, W. Giaretti, G. Corte, et al.
z-Leucinyl-Leucinyl-Norleucinal Induces Apoptosis of Human Glioblastoma Tumor-Initiating Cells by Proteasome Inhibition and Mitotic Arrest Response
Mol. Cancer Res.,
November 1, 2009;
7(11):
1822 - 1834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Meurette, S. Stylianou, R. Rock, G. M. Collu, A. P. Gilmore, and K. Brennan
Notch Activation Induces Akt Signaling via an Autocrine Loop to Prevent Apoptosis in Breast Epithelial Cells
Cancer Res.,
June 15, 2009;
69(12):
5015 - 5022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hiruma, T. Honjo, D. F. Jelinek, J. J. Windle, J. Shin, G. D. Roodman, and N. Kurihara
Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation
Blood,
May 14, 2009;
113(20):
4894 - 4902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Quillard, S. Coupel, F. Coulon, J. Fitau, M. Chatelais, M.C. Cuturi, E. Chiffoleau, and B. Charreau
Impaired Notch4 Activity Elicits Endothelial Cell Activation and Apoptosis: Implication for Transplant Arteriosclerosis
Arterioscler Thromb Vasc Biol,
December 1, 2008;
28(12):
2258 - 2265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-M. Shin, D. J. Shaffer, H. Wang, D. C. Roopenian, and H. C. Morse III
NOTCH Is Part of the Transcriptional Network Regulating Cell Growth and Survival in Mouse Plasmacytomas
Cancer Res.,
November 15, 2008;
68(22):
9202 - 9211.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|